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A Randomized Clinical Trial to Reduce Patient Prehospital Delay to
Treatment in Acute Syndrome
Abstract
Background— Delay from onset of acute coronary syndrome (ACS) symptoms to hospital admission
continues to be prolonged. To date, community education campaigns on the topic have had disappointing
results. Therefore, we conducted a clinical randomized trial to test whether an intervention tailored
specifically for patients with ACS and delivered one-on-one would reduce prehospital delay time.
Methods and Results— Participants (n=3522) with documented coronary heart disease were randomized to
experimental (n=1777) or control (n=1745) groups. Experimental patients received education and
counseling about ACS symptoms and actions required. Patients had a mean age of 67±11 years, and 68% were
male. Over the 2 years of follow-up, 565 patients (16.0%) were admitted to an emergency department with
ACS symptoms a total of 842 times. Neither median prehospital delay time (experimental, 2.20 versus
control, 2.25 hours) nor emergency medical system use (experimental, 63.6% versus control, 66.9%) was
different between groups, although experimental patients were more likely than control to call the emergency
medical system if the symptoms occurred within the first 6 months following the intervention (P=0.036).
Experimental patients were significantly more likely to take aspirin after symptom onset than control patients
(experimental, 22.3% versus control, 10.1%, P=0.02). The intervention did not result in an increase in
emergency department use (experimental, 14.6% versus control, 17.5%).
Conclusions— The education and counseling intervention did not lead to reduced prehospital delay or
increased ambulance use. Reducing the time from onset of ACS symptoms to arrival at the hospital continues
to be a significant public health challenge.
Clinical Trial Registration— clinicaltrials.gov. Identifier NCT00734760.
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Abstract
Background—Delay from onset of acute coronary syndrome (ACS) symptoms to hospital
admission continues to be prolonged. To date community education campaigns on the topic have
had disappointing results. Therefore, we conducted a clinical randomized trial to test whether an
intervention tailored specifically for patients with ACS and delivered one-on-one would reduce pre-
hospital delay time.
Methods and Results—Participants (N=3522) with documented coronary heart disease were
randomized to experimental (n=1777) or control (n=1745) groups. Experimental patients received
education and counseling about ACS symptoms and actions required. Patients were mean age 67±11
years and 68% were male. Over the two years of follow-up, 565 patients (16.0%) were admitted to
an emergency department with ACS symptoms a total of 842 times. Neither median prehospital delay
time (experimental 2.20 vs. control 2.25 hours) nor emergency medical system use (experimental
63.6% vs. control 66.9%) was different between groups, although experimental patients were more
likely than control to call the emergency medical system if the symptoms occurred within the first 6
months following the intervention (p=0.036). Experimental patients were significantly more likely
to take aspirin following symptom onset than control patients (experimental 22.3% vs. control 10.1%,
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What is Known
1. The time from the onset of symptoms of acute coronary syndrome (ACS) to arrival at the hospital continues to be far too long to
achieve optimal benefit from reperfusion therapy in a majority of cases.
2. Three-quarters of the time related to prehospital delay in ACS is the result of patients’ failure to call the emergency medical system
(EMS).
3. Community education programs have been ineffective in changing prehospital delay times in ACS over the past two decades.
What this Article Adds
4. This was the first randomized clinical trial of an educational intervention for patients at high risk for ACS.
5. The intervention did not result in reduced prehospital delay or increased EMS use, but resulted in increased aspirin use by patients
prior to hospital admission.
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p=0.02). The intervention did not result in an increase in emergency department utilization
(experimental 14.6% vs. control 17.5%)
Conclusions—The education and counseling intervention did not lead to reduced pre-hospital
delay or increased ambulance use. Reducing the time from onset of acute coronary syndrome
symptoms to arrival at the hospital continues to be a significant public health challenge.
Individuals who experience the signs and symptoms of acute coronary syndrome (ACS) often
delay seeking treatment.1,2 Unfortunately, a delay of only a few hours can have a significant
impact on patient survival,3 with a 30 minute delay reducing average life expectancy by 1 year.
4 In recognition of the detrimental effect of prehospital delay on morbidity and mortality, the
National Heart Attack Alert Program5 advocates a goal of one hour (i.e., the “golden hour”
similar to that in trauma care) from ACS symptom onset to opening the coronary artery by
reperfusion or angioplasty. Unfortunately, the median prehospital delay times have remained
far longer at 2.3 to 6 hours.6–8 Over three-quarters of this delay time is related to the decision
process undertaken by the patient, with less than one-quarter related to transport time.9
To date, all interventions to reduce prehospital delay in ACS have involved community
education strategies designed to educate the general public. 10 Interventions have focused on
educating the public about the signs and symptoms of ACS, the importance of calling
emergency services, and the availability of treatments such as fibrinolysis and primary
coronary intervention. With few exceptions, these community-based interventions have failed
to reduce prehospital delay.10
Recognizing the complex cognitive, social and emotional processes involved in having patients
identify ACS symptoms correctly and seek care immediately, we conducted a randomized
controlled trial to test an education and counseling intervention designed specifically for
individuals at high risk for a future ACS event. The intervention was aimed at reducing the
time from ACS symptom onset to arrival at the hospital by increasing patients’ knowledge
about cardiac symptoms, and improving their attitudes and beliefs about seeking care
immediately when they experience ACS symptoms by calling 911. The primary study
hypothesis was that patients who received a face-to-face education and counseling intervention
and who experienced symptoms of ACS during two-years of follow-up would have reduced
prehospital delay time compared to control. Secondary hypotheses focused on use of
emergency medical services (EMS) and aspirin. We also examined the effect of the intervention
on emergency department (ED) utilization.
Methods
Following review and approval of the study protocol by the Institutional Review Boards at all
the participating institutions, we enrolled 3,522 patients with diagnosed ischemic heart disease
into a randomized controlled trial known as PROMOTION (Patient Response tO Myocardial
Infarction following a Teaching Intervention Offered by Nurses) from 2002 to 2004 and were
followed for two years following their enrollment. Participants provided written, informed
consent prior to randomization. The study design has been described previously.11 Briefly, it
consisted of randomization to one of two arms: 1) the experimental arm included a single, face-
to-face educational session conducted by a nurse with expertise in cardiology, followed by
telephonic reinforcement at one month by the same nurse, or 2) the control arm consisting of
usual care. Physicians caring for patients and nurses collecting follow-up data were blinded to
study assignment.
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Sample
Patients were recruited from in-hospital cardiovascular and cardiac catheterization units and
from a variety of out-patient clinics, cardiac rehabilitation programs and community medical
practices in the United States (n=1985, 56%) and Australia or New Zealand (n=1537, 44%).
Patients were eligible for the study if they had a diagnosis of ischemic heart disease, confirmed
by their physician or hospital medical record, and if they lived independently (i.e., not in an
institutional setting). Patients were excluded if they had any of the following: complicating
serious co-morbidity such as a psychiatric illness or untreated malignancy, neurological
disorder with impaired cognition, or inability to read or understand English.
Procedure
Data were collected in six sites: Los Angeles, California; Lexington, Kentucky; San Diego,
California; Seattle, Washington; Sydney, Australia; and Auckland, New Zealand. The
University of California, San Francisco served as the project and data coordinating center.
Baseline data were collected by means of a face-to-face meeting conducted in a place
convenient to the patient (e.g., out-patient clinic, physician’s office, or patient’s home)
following enrollment and prior to randomization. All data were collected using standardized
paper and pencil instruments. Subsequent data using similar questionnaires were collected at
3, 12, and 24 months in the physician’s office or patient’s home, or by telephone after the
patients had received a mailed copy of the data collection instruments. A summary of the study
design and number of participants at each data collection point is presented in Figure 1.
All patients were asked to inform the research office using a 24-hour toll free number if they
had sought medical treatment for symptoms of ACS. To encourage complete follow-up data,
however, all participants were called every 6 months and asked if they had experienced ACS
symptoms and sought medical care. In all cases of admission to the emergency department for
a possible ACS event, medical records were reviewed to determine the admitting and discharge
diagnoses, prehospital delay time, mode of transport to the hospital, and aspirin use prior to
admission. Follow-up continued for two years. All data collected at each of the participating
sites were entered via internet into a secure database specifically designed for the study with
appropriate privacy safeguards as dictated by the Health Insurance Portability and
Accountability Act.
Intervention
The intervention was based on Leventhal’s self regulatory model of illness behavior12,13 in
which ACS symptoms serve as a stimulus that must be processed both cognitively and
emotionally; an action plan is then developed and its effectiveness is appraised by the patient,
with the plan revised based on that appraisal. Patients received education in the three areas
recommended to physicians by National Heart Lung and Blood Institute Working Group on
Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute
Myocardial Infarction: namely, information about ACS, anticipated emotional issues and
social factors that could affect delay.5
Information—Patients were given standardized information about typical and atypical
symptoms of ACS and possible variability in symptom presentation. Patients were told that
they might experience chest pressure or discomfort that was intermittent rather than constant,
and that diaphoresis, shortness of breath, and pain radiation to parts of the body other than the
left arm (e.g., neck or back) were also possible symptoms of ACS. They were advised to call
EMS immediately. At the time of the development of the educational intervention, patients
who had no contraindiciations were encouraged to take one non-enteric coated aspirin prior to
arrival at the hospital as well as nitroglygerin (if prescribed), and this instruction was included.
14
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Emotional component—Patients were asked to anticipate the emotional responses to ACS
symptoms that might lead to delay, as well as to discuss their previous experiences accessing
the medical system. The rewards of seeking treatment immediately were emphasized and
emotional issues were addressed through role playing scenarios that were standardized across
intervention group patients.
Social Factors—Patients were asked to bring their spouse, another family member or friend
to the intervention session whenever possible. These individuals were “deputized” to act as the
decision maker if the patient hesitated to call EMS. The potential reaction of the family member
was discussed (e.g., denial, fear, ambivalence, etc.) and the importance of and rewards for
quick action were underscored.
An advisory form5 that included the appropriate steps to take with onset of ACS symptoms
was provided at the end of the intervention session. Patients were asked to post the advisory
form in a prominent place in the house (e.g., on the refrigerator or by the phone). The
intervention was standardized with a flip chart so that patients and family members received
the same information components, but it was tailored to the patient’s own past medical
experience and unique living situation. The information was delivered in a quiet, private
outpatient setting such as a room in the clinic office or the patient’s home and was
approximately 40 minutes in length. One month following the initial intervention session, the
nurse who had provided the intervention called each patient and reviewed the main points from
the initial session. The average length of the phone call was 15 minutes.
Measurements
Prehospital delay—Time from symptom onset to hospital presentation was obtained from
the hospital medical record or, in those cases with no notation in the medical record, from the
EMS prehospital medical reports.
Mode of transportation—Emergency department records were used to identify mode of
transport to the hosptial. To verify transport by the paramedic system, we checked all data
against the EMS prehospital medical reports.
Aspirin use—Aspirin use prior to hospital admission was evaluated by review of the ED
medical record and verified by patient interview following emergency department admission.
Sociodemographic and clinical characteristics—All participants completed a paper
and pencil questionnaire describing sociodemographic characteristics, insurance status, and
clinical history. Race was obtained by self-report and was requested because previous
researchers have identified race and/or ethnicity as variables influencing prehospital delay.2,8
Knowledge, attitudes and beliefs about ACS—These variables were measured at
baseline, 3 and 12 months in both experimental and control groups as a test of the fidelity of
the intervention using the ACS Response Index, an instrument originally developed for the
Rapid Early Reaction for Coronary Treatment (REACT) study to measure knowledge, attitudes
and beliefs about coronary heart disease7 and modified for use in the current study.15
Reliability was tested using Cronbach’s alpha and was judged adequate at .82, .71 and .74
respectively for the three scales of knowledge, attitudes and beliefs.
Statistical Analyses
Baseline characteristics of the control and experimental groups were compared using Chi-
square tests for categorical data and independent t-tests for continuous variables. To test the
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saliency of the intervention, we assessed knowledge, attitudes and beliefs over time (baseline,
3 and 12 months) using repeated measures analysis of variance (ANOVA).
Since prehospital delay time was positively skewed, we used log transformed prehospital delay
times for all analyses to make the distribution more nearly Gaussian. Sample size was
calculated based on the mean and median prehospital delay times previously identified in 474
AMI patients in sites similar to those proposed in the current study.16 In that study, mean delay
was 11.2 (SD 21.6) hours with a median delay of 3.3 hours. Using the natural log of the
transformed mean (1.4) and standard deviation (1.4), we targeted a 25 percent reduction in
delay time, reflecting a small to medium effect size (0.2857, t (386)=1.966). Using alpha =
0.05 and beta = 0.20, data on 388 patients were required to have adequate power to detect a
significant difference in the prehospital delay time between the two groups.17 Based on a
previous study in which a reduction in delay to treatment of 30 minutes led to a significant
reduction in morbidity and mortality,4 the target of a 25 percent reduction was identified as
clinically significant.
A mixed linear model was used to assess the effect of the intervention on log transformed
prehospital delay with the intercept parameters specified as random. In those cases where
prehospital delay time was missing in the medical record or EMS record, values were not
imputed. Similarly, a random-effects logistic model was used to compare the use of ambulance
during ER visits and aspirin use between the experimental and control groups and missing
values were not imputed. Random effects were used in all analyses to account for the within-
patient correlation of the outcomes because some patients had more than one emergency visit.
Treatment assignment, time since randomization, and the time-by-treatment interaction, as well
as age, gender, BMI, insurance coverage for ambulance use, and medical history were treated
as fixed effects based on previous research1,2,5,6 suggesting that these variables might
influence patients’ adherence to the recommended actions, our interest in understanding if
patients were more likely to follow recommendations in the time immediately following the
intervention (i.e., within 6 months) compared to a time more distant from the intervention
session, and baseline differences between the experimental and control groups. Tests were two-
sided, and p-values <0.05 were considered statistically significant. All analyses were run using
Stata 9.0 software (Stata Corp, College Station, TX or SPSS version15.0).
Results
On average, patients who enrolled in the study were 67 (SD 11) years old and 68% were male.
The majority was married (71%), employed (72%), being care for by a cardiologist (83%), and
had insurance for visits to the ED (96%). A check on randomization revealed no significant
differences between groups on a variety of demographic and clinical variables except for body
mass index (p=0.048), gender (with more females in the experimental group than control,
p=0.02), and insurance for ambulance use (with more patients with insurance in the control
group compared to the experimental group, p=0.04) (Table 1).
Despite having a history of coronary heart disease, 38% of patients had significant gaps in
knowledge about ACS at baseline, as documented by scores of less than 70% on the Knowledge
Scale of the ACS Response Index. The mean cardiac knowledge score for the entire sample
on the ACS Response Index was 71% (SD 12%) with a range of 8 to 100%.18 There was no
significant difference in baseline knowledge scores on the ACS Response Index between the
two treatment groups at baseline (Table 1). In comparing the groups over time, all three scales
were significantly higher in the experimental group compared to the control group over time
(p<0.0005), indicating that the intervention increased knowledge and influenced attitudes and
beliefs in the hypothesized direction.
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Clinical Outcomes
Of the 3522 subjects originally enrolled, 142 (4%) were deceased at 24 months, 75 (4.3%) in
the experimental group and 67 (3.8%) in the control group (p = 0.426). One hundred eighty-
three (5.2%) were lost to follow-up, and 110 (3.1%) withdrew from the study. Therefore, the
two-year follow-up was conducted on 3087 (87.6%) subjects. A total of 565 (16.0%) patients
presented to the ED with symptoms of ACS for a total of 842 admissions. Of the 565 patients,
260 (46%) were in the control group and 305 (54%) were in the experimental group. Of the
842 ED admissions, 408 (48%) were in the control group and 434 (52%) were in the
experimental group. The patients who sought care for ACS symptoms are described in Table
2. Delay time was recorded in the medical record in 595 (71%) of the 842 cases. Data were
available on the mode of transport in 708 (97.0%) cases and on the use of non-enteric coated
aspirin by the patient prior to ED admission in 674 (92.3%) of cases.
Clinical outcomes are summarized in Table 3. The median time from symptom onset to hospital
admission was 2.20 hours for the experimental group compared to 2.25 hours for the control
group. The regression coefficient for the treatment variable was the difference in log times
between the experimental and control groups and this difference was not significant (p=0.40).
Mean prehospital delay time was 22 minutes shorter on average in the experimental group than
the control group, but this difference was not significant and was primarily caused by a few
patients in the control group who incurred exceedingly long prehospital delay times (i.e.,
greater than 12 hours). In an unadjusted mixed linear model analysis, the intervention resulted
in a decreased prehospital delay time of 3.3% (95% CI −10.9% to 4.3%, p=0.40) with the
percent change calculated as the difference in prehospital delay times between the experimental
and control groups divided by the control group prehospital delay time. When potentially
confounding variables (i.e., time since randomization, age, gender, BMI, insurance for
ambulance use and medical history) were adjusted in the analysis, the intervention resulted in
a decreased prehospital delay time of 1.02% (95% CI −9.59 7.54, p=0.82).
Sixty-four percent of patients in the experimental group and 67% of patients in the control
group used EMS. Comparing these values using an unadjusted random effects logistic model,
the differences were not significant (p=0.89). However, using an adjusted random effects
logistic model, we found an interaction between group assignment and time from
randomization to symptom onset (p=0.009). We then compared patients who experienced
symptoms within six months of study entry and those who experienced symptoms later than
six months. Patients in the experimental group were more likely to use EMS if the ACS
symptoms occurred early in the study, i.e., within the first 6 months following group assignment
(p=0.036). It was also noted that when all patients who used EMS were analyzed by country,
66.7% were Australian while only 33.3% were from the U.S..
Approximately twice as many patients in the experimental group compared to control group
took aspirin following symptom onset (22.3% vs 10.1% respectively) and the difference by
group assignment was significant according to a mixed models random effects analysis (p=.
024). Using an adjusted random effects logistic model, the time from randomization to ED
visit was a significant predictor of aspirin use (OR 1.93, CI 1.09–3.43, p=0.024).
Receiving education and counseling about the need to respond quickly to ACS symptoms did
not result in increased ED use. In fact, over the two years of follow-up 17.5% of patients in
the control group sought care in an ED for symptoms of ACS compared to 14.6% of patients
in the experimental group over the two years of follow-up. This difference in ED utilization
between groups was not significant (p>0.05).
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Discussion
Today almost 14 million Americans have established coronary artery disease, which increases
their risk for a future ACS event.19 Delay in contacting the health care system in the face of
cardiac symptoms remains a major obstacle to definitive treatment of patients with acute
myocardial infarction and may contribute to out-of-hospital cardiac deaths. The study reported
here was the first randomized controlled trial designed specifically for a population at high risk
for a future ACS event and targeting a reduction in prehospital delay. We documented the
effects of a face-to-face, tailored education and counseling intervention on prehospital delay
time (the primary hypothesis), as well as EMS and aspirin use, as well as utilization of the ED
(secondary hypotheses). The primary hypothesis was rejected. While aspirin use was
significantly higher in the experimental group, the use of EMS was not significantly different.
However, utilization of ED resources was not significantly increased by the intervention.
The intervention was designed to encourage patients to personalize the message to seek care
quickly in the face of ACS symptoms and to counter emotional coping mechanisms such as
denial that might lead to prolonged prehospital delay time. The intervention protocol was based
on the recommendations of the National Heart Attack Alert Program5 and the findings were
particularly disappointing given the tailored nature of the intervention and the high risk status
of the sample for a future ACS event. Unlike previous interventions designed for community-
dwelling individuals,7,10 the current study was tailored for patients aware of their risk for a
future ACS event who could be expected to be more attentive to health messages than
individuals living in the community.
Upon reflecting on the negative study findings of no difference in median prehospital delay
times between the two experimental groups, several interpretations can be offered. First, data
collection may have provided an unintended form of intervention in the control group. All
patients enrolled in the current study completed questionnaires at baseline, 3 and 12 months
following enrollment and responded to questions in which they were asked to identify cardiac
symptoms, describe their attitudes toward seeking help quickly if symptoms occurred, and state
the level of their belief that the medical system had treatments that would help them if they
sought care quickly. Reflecting on these questions at three different times and actively
responding in writing to each of them may have sensitized control patients to the importance
of seeking care early. Perhaps a third study arm that represented a true control without periodic
assessment of knowledge, attitudes and beliefs would have revealed that the data collection
process itself was a form of intervention. The fact that, with the exception of the Physicians
Health Study (median delay time of 114 minutes),20 the delay times in both the experimental
and control groups was shorter than in all previous studies reported to date10 supports this
interpretation.
Second, another explanation for the lack of effect of the face-to-face tailored intervention may
be that the information presented did not address the variability of onset and the differing
symptoms of ACS adequately or was not of sufficient intensity or duration to address the
patients’ denial or inappropriate attribution of symptoms. The education and counseling session
was delivered by a research nurse, not the patient’s physician. The latter may have been able
to adapt the information provided the patient to the unique medical history, including the nature
of previous ACS symptoms and patterns of response. Similarly, the fact that patients in the
experimental group were more likely to call the EMS if ACS symptoms occurred early in the
study (i.e., in the first six months from enrollment) suggests that repetition of the information
might increase the saliency of the intervention.
A third interpretation relates to difference between the two study groups. Despite
randomization, there were significantly more women in the experimental group than the control
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group (34 vs. 30 percent respectively, p=0.02). This difference may have contributed to the
finding of no difference in median delay times, although gender was used as a covariate in the
analysis. Although gender was not significantly different in the two groups who sought care
for ACS symptoms (38 vs 32 percent in the experimental and control groups respectively,
p=0.11), the difference in percentages may have favored longer median delay times in the
experimental group. Some investigators6 have noted that women delay longer than men in
seeking care for cardiac symptoms, although the reason for this difference by gender remains
unknown. Similarly, the two groups who presented to the ED for symptoms of ACS were
significantly different in their annual incomes and ambulance insurance, with the experimental
group reporting lower income and less insurance coverage. Both factors would favor longer
delays in the experimental group if patients were concerned about the cost of care and therefore
may have contributed to the finding of no difference between the groups; however, these
differences were handled as covariates in the analysis and therefore do not provide a strong
explanation for the findings of no difference in prehospital delay times.
We were surprised at the high EMS use in both groups, which was twice the level of the 33%
EMS use documented in REACT at baseline7 or the National Registry of Myocardial
Infarction.21 Our findings may be a reflection of the large proportion of patients recruited from
Australia and New Zealand (44%) where ambulance use is generally high and is covered by
universal health care. In fact, 87% of all patients in the study had insurance coverage for EMS
use, which may have contributed to the high ambulance use and the relatively short prehospital
delay. Many investigators7,22 have noted the importance of accessing EMS to reduce
prehospital delay time, as well as minimize delay to treatment once the patient is admitted to
the hospital.
Although the intervention did not influence prehospital delay times or EMS use, it did result
in a significantly higher percentage of patients who took aspirin in the face of acute symptoms.
It is important to note that researchers have suggested that self treatment is a source of delay,
23 and therefore the recommendation to take aspirin prior to hospital arrival is no longer given.
24 However, our findings suggest that patients are willing to adopt this behavior, which is a
relatively simple one compared to calling EMS. The significant difference between groups on
this one outcome underscores the complexity of designing an intervention that will reduce the
many psychological barriers to calling 911 that exist for patients and their family members in
the face of ACS symptoms. Behaviors such as taking aspirin appear to be easier to change than
calling EMS or seeking care in an ED immediately upon onset of cardiac symptoms.
One of the concerns about conducting a large-scale intervention to decrease prehospital delay
in ACS is that patients will become anxious and emergency department utilization will increase
inappropriately. It is important to note that the intervention did not increase emergency room
use in the experimental group, a finding that is similar to that of other community intervention
studies.7,18,25.
Conclusion
A relatively short, one-on-one education and counseling intervention significantly increased
knowledge, attitudes and beliefs about ACS and response to ACS symptoms. The intervention
did not reduce pre-hospital delay time or increase EMS use, although it did increase the
patients’ use of aspirin prior to arrival at the hospital. The decision to seek care promptly with
the onset of ACS symptoms and use of EMS rather than other modes of transportation continues
to be a significant public health challenge. Further research is required to determine how best
to encourage patients who experience symptoms of ACS to seek care promptly.
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Figure 1.
CONSORT flow diagram
Dracup et al. Page 11
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2010 November 1.
Dracup et al. Page 12
Table 1
Sociodemographic and clinical characteristics (N=3522)
Patient Characteristics Total Experimental (n=1777) Control (n=1745) p
Age (yrs) 0.856
 <65 1352 690 (38.8%) 662 (38.0%)
 65–79 1751 876 (49.3%) 875 (50.2%)
 80+ 417 211 (11.9%) 206 (11.8%)
Gender 0.023
 Male 2393 1176 (66.2%) 1217 (69.7%)
 Female 1129 601 (33.8%) 528 (30.3%)
Marital Status 0.795
 Not currently married 994 499 (28.5%) 495 (28.9%)
 Married or cohabit 2468 1251 (71.5%) 1217 (71.1%)
Working Status 0.816
 Unemployed 2517 1272 (71.8%) 1245 (71.4%)
 Employed 998 500 (28.2%) 498 (28.6%)
Education 0.963
 Some High School 557 280 (15.8%) 277 (15.9%)
 Completed High School 641 318 (17.9%) 323 (18.5%)
 Some College/Technical 1326 673 (37.9%) 653 (37.5%)
 Completed College 994 505 (28.4%) 489 (28.1%)
Annual Income 0.550
 <$15,000 726 353 (22.2%) 373 (23.6%)
 $15,000–$30,000 719 366 (23.0%) 353 (22.4%)
 $30,000–$45,000 554 266 (16.7%) 288 (18.2%)
 $45,000–$60,000 456 236 (14.8%) 220 (13.9%)
 >60,000 715 370 (23.3%) 345 (21.8%)
Insurance 0.809
 Uninsured, Govt., VA 1774 890 (50.4%) 884 (50.8%)
 Any Private 1732 876 (49.6%) 856 (49.2%)
Insured for ambulance use 0.044
 No 353 196 (12.7%) 157 (10.4%)
 Yes 2698 1344 (87.3%) 1354 (89.6%)
Insured for visit to the ED 0.775
 No 141 73 (4.3%) 68 (4.1%)
 Yes 3231 1633 (95.7%) 1598 (95.9%)
Ethnicity 0.900
 White 3207 1617 (91.0%) 1590 (91.1%)
 Non-White 315 160 (9.0%) 155 (8.9%)
 Asian-Pacific Islander 126 62 (3.5%) 64 (3.7%)
 Black 62 33 (1.9%) 29 (1.7%)
 Hispanic 42 22 (1.2%) 20 (1.1%)
 Native American 33 17 (1.0%) 16 (0.9%)
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Patient Characteristics Total Experimental (n=1777) Control (n=1745) p
 Other 52 26 (1.5%) 26 (1.5%)
History of Angina 0.997
 No 1365 695 (40.3%) 670 (39.5%)
 Yes 2056 1029 (59.7%) 1027 (60.5%)
History of MI 0.619
 No 1536 786 (45.4%) 750 (44.1%)
 Yes 1894 944 (54.6%) 950 (55.9%)
History of PTCA 0.438
 No 1813 908 (51.9%) 905 (52.3%)
 Yes 1666 841 (48.1%) 825 (47.7%)
History of stent 0.815
 No 2087 1050 (59.8%) 1037 (60.0%)
 Yes 1398 707 (40.2%) 691 (40.0%)
History of PTCA +/− stent 0.880
 No 1749 883 (50.2%) 866 (49.9%)
 Yes 1743 875 (49.8%) 868 (50.1%)
History of CABG 0.866
 No 1896 975 (55.0%) 921 (52.9%)
 Yes 1618 799 (45.0%) 819 (47.1%)
History of PVD 0.228
 No 2998 1530 (89.9%) 1468 (88.2%)
 Yes 367 171 (10.1%) 196 (11.8%)
History of diabetes 0.108
 No 2740 1382 (78.2%) 1358 (78.4%)
 Yes 759 385 (21.8%) 374 (21.6%)
History of stroke 0.889
 No 3116 1565 (89.4%) 1551 (90.3%)
 Yes 353 186 (10.6%) 161 (9.7%)
Current smoker 0.380
 No 3288 1665 (93.8%) 1623 (93.3%)
 Yes 227 110 (6.2%) 117 (6.7%)
History of smoking 0.525
 No 1311 681 (38.4%) 630 (36.2%)
 Yes 2204 1094 (61.6%) 1110 (63.8%)
History of hypercholesterolemia 0.186
 No 1164 601 (34.6%) 563 (32.8%)
 Yes 2288 1135 (65.4%) 1153 (67.2%)
History of hypertension 0.260
 No 1532 765 (43.7%) 767 (44.5%)
 Yes 1944 986 (56.3%) 958 (55.5%)
Sedentary lifestyle 0.646
 No 2343 1179 (66.8%) 1164 (67.3%)
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 Yes 1153 587 (33.2%) 566 (32.7%)
Cardiologist 0.743
 No 573 296 (16.7%) 277 (15.9%)
 Yes 2933 1472 (83.3%) 1461 (84.1%)
Attended cardiac rehabilitation 0.520
 No 1595 837 (49.2%) 758 (45.8%)
 Yes 1763 865 (50.8%) 898 (54.2%)
BMI 0.048
 <25 kg/m2 1111 549 (32.4%) 562 (34.1%)
 25–30 kg/m2 1375 683 (40.3%) 692 (42.0%)
 30+ kg/m2 854 461 (27.2%) 393 (23.9%)
X (SD) X (SD)
Score on ACS Response Index (%
correct)
70.9 (11.2) 70.8 (11.5) 0.987
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Table 2
Comparison of characteristics of patients admitted to the emergency department for ACS symptoms (N=565)
Baseline characteristics Experimental (n=305) Control (n= 260) p
Sociodemographic Characterisitics
Age, Mean ± SD (years) 67.5 ± 12.3 68.2 ± 10.8 .53
Female gender, %(n) 38.0 (116) 31.5 (82) .11
≥ College education, %(n) 33.8 (24) 27.7 (23) .48
Annual household income < $30,000), %(n) 29.2 (19) 50.0 (39) .02
Fulltime or part-time employment 28.1 (85) 21.2 (55) .06
U.S. resident 48.5 (148) 48.8 (127) .94
Health insurance for ambulance 86.7 (235) 92.7 (217) .03
Cardiac Risk Factors, %(n)
Current smoker 7.2 (22) 5.4 (14) .39
Diabetes 20.1 (61) 26.5 (68) .07
Hypertension 61.4 (183) 62.3 (160) .84
Dyslipidemia 66.8 (197) 67.5 (172) .87
BMI ≥ 25 kg/m2 43.7 (31) 34.9 (29) .32
Sedentary lifestyle 22.5 (16) 17.9 (15) .55
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Table 3
Prehospital delay, EMS and aspirin use during two-years follow-up.
Experimental Control
Prehospital delay ┼ 317 ED visits
(n = 224)§
278 ED visits
(n= 169)
Median prehospital delay time (hours) 2.20 2.25
 25 percentile 1.18 1.18
 75 percentile 4.69 5.28
Mean prehospital delay time (± SD) 4.29 (± 0.34) 5.08 (± 0.69)
Transportation mode § 373 ED visits
(n = 305)
334 ED visits
(n = 260)
 Ambulance/Helicopter: % (n) 63.6 (194) 66.9 (174)
 Private car/other: % (n) 58.7 (179) 61.5 (160)
Aspirin use prior to ED arrival § 367 ED visits
(n = 259 )
307 ED visits
(n =212 )
 Yes: % (n) 22.3 (82) 10.1 (31)
 No: % (n) 77.7(285) 89.9 (276)
Note:
┼
Prehospital delay time (time from symptom onset to ED arrival) was obtained from patients’ medical records. Due to missing data, sample sizes in
prehospital delay time, transportation mode, and aspirin use are not equivalent.
§
n refers to the number of patients in each group
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